Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/14/2001CN1321678A Novel polypeptide-human kruppel related DNA bindin 42 and polynucleotide for coding this polypeptide
11/14/2001CN1321677A Novel polypeptide-human Pax protein 11.9 and polynucleotide for coding this polypeptide
11/14/2001CN1321676A Novel polypeptide-human NPAT protein 12 and polynucleotide for coding this polypeptide
11/14/2001CN1321675A Novel polypeptide-human P18 protein 21 and polynucleotide for coding this polypeptide
11/14/2001CN1321674A Novel polypeptide-human NPAT protein 15 and polynucleotide for coding this polypeptide
11/14/2001CN1321673A Novel polypeptide-human erythrocytic adducin alpha subunit 11 and polynucleotide for coding this polypeptide
11/14/2001CN1321672A Novel polypeptide-human myoglobulin heavy chain 12-14 and polynucleotide for coding this polypeptide
11/14/2001CN1321671A Novel polypeptide-human ribosomal protein 13 and polynucleotide for coding this polypeptide
11/14/2001CN1321670A Novel polypeptide-human protein 9 containing trans glutaminase active site and polynucleotide for coding this polypeptide
11/14/2001CN1321669A Novel polypeptide-human myb protein 10 and polynucleotide for coding this polypeptide
11/14/2001CN1321667A Novel polypeptide-human chicken wing deformation protein FH2-23 and polynucleotide for coding this polypeptide
11/14/2001CN1321666A Novel polypeptide-human myoglobulin heavy chain 11 and polynucleotide for coding this polypeptide
11/14/2001CN1321665A Novel polypeptide-human thyroglobulin 38 and polynucleotide for coding this polypeptide
11/14/2001CN1321663A Novel polypeptide-human Pax protein 18 and polynucleotide for coding this polypeptide
11/14/2001CN1321662A Novel polypeptide-human pax protein 11.7 and polynucleotide for coding this polypeptide
11/14/2001CN1321661A Novel polypeptide-human K-ras proto-oncogene protein 36 and polynucleotide for coding this polypeptide
11/14/2001CN1321660A Novel polypeptide-human laminin B2 strand 13 and polynucleotide for coding this polypeptide
11/14/2001CN1321659A Novel polypeptide-human laminin B2 strand 12 and polynucleotide for coding this polypeptide
11/14/2001CN1321657A Novel polypeptide-human myb protein 14 and polynucleotide for coding this polypeptide
11/14/2001CN1321656A Novel polypeptide-human Pax protein 11 and polynucleotide for coding this polypeptide
11/14/2001CN1321655A Novel polypeptide-human pax protein 10.3 and polynucleotide for coding this polypeptide
11/14/2001CN1321654A Novel polypeptide-human pax protein 11.4 and polynucleotide for coding this polypeptide
11/14/2001CN1321653A Novel polypeptide-human kruppel related DNA bindin 10 and polynucleotide for coding this polypeptide
11/14/2001CN1321652A Novel polypeptide-human protein 10 containing gamma-glutamyl transpeptidase signature sequence fragment and polynucleotide for coding this polypeptide
11/14/2001CN1321651A Novel-polypeptide-human kingle protein 15 and polynucleotide for coding this polypeptide
11/14/2001CN1321650A Novel polypeptide-cytokine receptor 10 and polynucleotide for coding this polypeptide
11/14/2001CN1321649A Novel polypeptide-central cannabis receptor 10 and polynucleotide for coding this polypeptide
11/14/2001CN1321645A Novel polypeptide-KIAA0883-44 polynucleotide for coding this polypeptide
11/13/2001USRE37447 Modified Kluyveromyces yeasts, their preparation and use
11/13/2001US6316699 Plants with modified stamen cells
11/13/2001US6316698 Nucleotide sequence coding plant enzymatic polypeptide; for use in adjusting starch content in plants and seeds
11/13/2001US6316697 Constitutive disease resistance(CDR1) gene and methods of use thereof
11/13/2001US6316695 Isopentenyl diphosphate isomerase from Hevea brasiliensis and rubber producing method using the same
11/13/2001US6316694 Generating genetically engineered plants; infect embryogenic microspore with agrobacteria, culture infected cells, remove agrobacteria, culture transformed cells
11/13/2001US6316693 Transgenic mouse model for fatty acid transport
11/13/2001US6316692 Insertion of nucleotide sequences into genomes; inject sample into testes, recover preferential polypeptide from transformed cells
11/13/2001US6316690 Non-mammalian transgenic animal model for cellular proliferative diseases
11/13/2001US6316689 25-hydroxyvitamin D3 24-hydroylase transgenic rats
11/13/2001US6316614 Generation of water-soluble polysaccharide; obtain a mutant of xanthamonas, culture the mutant, and recover polysaccharide
11/13/2001US6316612 Can be used for chemical synthesis of nucleotide-triphosphates and/or phosphoramidites as building blocks for selective incorporation into oligonucleotides, these oligonucleotides can be used as an antisense molecule, 2-5a antisense chimera
11/13/2001US6316611 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/13/2001US6316609 Nucleotide sequence of Escherichia coli pathogenicity islands
11/13/2001US6316608 Polynucleotides; for use in dection and measurement of preferential particles in sample
11/13/2001US6316604 Purification of genetically engineered complement receptor; express complement receptor in cells, obtain sample, subject to chromatography column, elute receptor protein
11/13/2001US6316603 Modifications of the VEGF receptor-2 protein and methods of use
11/13/2001US6316601 Antibodies specific for β6 integrins
11/13/2001US6316597 Protein for use in treatment of bone or cartilage defects
11/13/2001US6316422 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
11/13/2001US6316421 Pentaerythritol lipid derivatives and nuleic-acid complexes
11/13/2001US6316419 Induction of angiogenesis in heart muscle by a DNA sequence encoding an angiogenic protein
11/13/2001US6316418 Regulated apoptosis
11/13/2001US6316412 Polypeptides for promoting cell attachment
11/13/2001US6316409 Modified ligands of calcium-dependent binding proteins
11/13/2001US6316408 Methods of use for osetoprotegerin binding protein receptors
11/13/2001US6316407 Polypeptides as antigrowth agents for plants
11/13/2001US6316262 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids
11/13/2001US6316261 Method for concerted integration of donor DNA molecules using retroviral integrase proteins
11/13/2001US6316260 Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof
11/13/2001US6316259 Antisense inhibition of glycogen synthase kinase 3 alpha expression
11/13/2001US6316258 Inhibiting angiotensin/renin induced generation of transforming growth factor; mix renin with modulator and sample, incubate, evaluate sample for reduced generation of transforming growth factor
11/13/2001US6316257 Generating preferential blood cells in culture; mix blood cells, activators and interleukins, incubate evaluate cell amplification
11/13/2001US6316255 Transduced cultured liver cells; for use in the treatment and prevention of liver disorders
11/13/2001US6316254 Methods for stimulating erythropoiesis using hematopoietic proteins
11/13/2001US6316253 Plasmid for use as a tool in genetic engineering and gene transfer
11/13/2001US6316252 Biotherapeutic delivery system
11/13/2001US6316251 Gene, group of genes, and novel β-gluclosidase
11/13/2001US6316250 Molecular clones producing recombinant DNA antigens of the hantavirus-associated respiratory distress (HARDS)
11/13/2001US6316248 Isolating nucleotide sequences from preferential cells; soak cells in extraction solution, recover preferential cells
11/13/2001US6316242 Method for producing nitrile hydratase
11/13/2001US6316239 HKABY60 kinase family polypeptides
11/13/2001US6316238 Process for producing activated human ALT
11/13/2001US6316237 Respiratory nitrate reductase alpha subunit
11/13/2001US6316232 Microbial preparation of substances from aromatic metabolism/I
11/13/2001US6316231 For fermentative conversion of l-sorbose;
11/13/2001US6316230 Polymerase extension at 3′ terminus of PNA-DNA chimera
11/13/2001US6316227 Dna sequence encoding a composite heavy chain of a recombinant antibody molecule that specifically binds human interleukin-5 antigen
11/13/2001US6316226 For use in treatment of hemophilia a
11/13/2001US6316224 Chlorella virus promoters
11/13/2001US6316223 Mammalian protein interaction cloning system
11/13/2001US6316222 Binds calcium-signal modulating cyclophilin ligand; use in identifying agents for modulating the calcium induced activation pathway
11/13/2001US6316221 Functional expression of pheromone binding protein
11/13/2001US6316220 Found in aspergillii
11/13/2001US6316219 Compounds
11/13/2001US6316217 Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same
11/13/2001US6316216 Mutated prenyl diphosphate synthases
11/13/2001US6316210 Genetic suppressor elements against human immunodeficiency virus
11/13/2001US6316208 Methods for determining isolated p27 protein levels and uses thereof
11/13/2001US6316206 Method for screening comprising cells expressing the CNTF receptor
11/13/2001US6316204 Methods for detecting fohy030 polypeptide
11/13/2001US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001US6316202 Nucleic acids encoding cold sensitive mutant DNA polymerases
11/13/2001US6316200 Monitoring target nucleotide sequences; generate adaptor nucleotide sequences, hybridize reporter molecules to nucleotide sequences, detect hybridization products
11/13/2001US6316199 Arginase II
11/13/2001US6316198 Detection of mutations in genes by specific LNA primers
11/13/2001US6316196 Methods for analyzing LTC4 synthase polymorphisms and diagnostic use
11/13/2001US6316193 Complimentary nucleotide sequences for use as tool in genome analysis
11/13/2001US6316192 Preferential elimination of amplifiable targeted nucleotide sequences; join nucleic acids to adaptors, amplify, mix primers, probes and nucleotide sequences, denature, anneal, remove unwanted nucleotides, duplicate process
11/13/2001US6316189 Evaluation of changes in breast cells using nipple aspirate fluid
11/13/2001US6316186 Determining concentration of particles in sample; incubate sample with binding agent, incubate sample with solid support, determine concentration of preferential particle in sample by monitoring binding
11/13/2001US6316182 Detection of reverse transcriptase by DNA hybridization assay